Healthcare Success

DECEMBER 10, 2024

Did you know Google changes its algorithm up to 200 times a day? Yet many healthcare organizations still rely on SEO strategies and tactics that were "best practices" a decade ago. Its no surprise that countless healthcare providers and other businesses are seeing drops in rankings and traffic after Google's Helpful Content Update. To help you navigate these changes and learn what you need to update, I invite you to listen to this podcast featuring Brandon Schakola.

Healthcare 109

Healthcare Healthcare Insurance Engineering 109

MedCity News

DECEMBER 10, 2024

Arcellxs cell therapy for multiple myeloma has shown no signs of the parkinsonism complication observed in clinical testing of Carvykti, a rival product from partners Johnson & Johnon and Legend Biotech. Arcellx is developing its CAR T-treatment under a partnership with Gilead Sciences. The post Safety Stands Out in Arcellx Cell Therapys ASH Data, But Dont Overlook Manufacturing Advantages appeared first on MedCity News.

Safety 100

Safety Manufacturing Biopharma Pharma 100

PharmaTimes

DECEMBER 10, 2024

New cell therapy shows potential in treating advanced blood disorder

101

101

MedCity News

DECEMBER 10, 2024

In a letter, Families USA and numerous other organizations called on Congress to extend the enhanced premium tax credits that are set to expire at the end of 2025. The post More Than 70 Organizations Urge Congress to Extend Enhanced Premium Tax Credits appeared first on MedCity News.

110

110

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

PharmaTimes

DECEMBER 10, 2024

New findings presented at international SCWD conference

89

89

Pharmaceutical Technology

DECEMBER 10, 2024

Seres Therapeutics has received US FDA breakthrough therapy designation for its SER-155, aimed at decreasing BSIs.

FDA 64

FDA 64

Pharmaceutical Technology

DECEMBER 10, 2024

While 88.

Patients 59

Patients 59

PharmExec

DECEMBER 10, 2024

This application note summarizes key SIFT-MS results presented in a peer reviewed article entitled Unreported VOC Emissions from Road Transport Including from Electric Vehicles. Learn how the Wolfson Atmospheric Chemistry Laboratory at the University of York used SIFT-MS for VOC analysis in its platform to experimentally verify that motor vehicle screen wash is a significant unreported source of VOC emissions (especially for ethanol and methanol).

Transportation 52

Transportation 52

Pharmaceutical Technology

DECEMBER 10, 2024

The results from the Phase III trial found the LDL-C treatment to be well tolerated with a reduction in low-density lipoprotein cholesterol.

59

59

PharmExec

DECEMBER 10, 2024

This study demonstrates high-throughput analysis of BTEX compounds from several matrices (air, water and soil). Detection limits in the single-digit part-per-billion concentration range (by volume) are readily achievable within seconds using SIFT-MS because sample analysis is achieved without chromatography, pre-concentration, or drying. We also present a calibration approach that enables speciation of ethylbenzene from the xylenes in real-time.

52

52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Technology

DECEMBER 10, 2024

The respiratory syncytial virus (RSV) prophylaxis market across the eight major markets (8MM) - comprising the US, the five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and Australia - is forecast to grow from $582m in 2020 to $6.2bn in 2030 at a compound annual growth rate of 26.7%, with the paediatric and adult segments accounting for $2.2bn and $4.0bn, respectively.

Marketing 59

Marketing 59

PharmExec

DECEMBER 10, 2024

This application note summarizes key SIFT-MS results presented in a peer reviewed article entitled Unreported VOC Emissions from Road Transport Including from Electric Vehicles. Learn how the Wolfson Atmospheric Chemistry Laboratory at the University of York used SIFT-MS for VOC analysis in its platform to experimentally verify that motor vehicle screen wash is a significant unreported source of VOC emissions (especially for ethanol and methanol).

Transportation 52

Transportation 52

Pharmaceutical Technology

DECEMBER 10, 2024

The EMA has validated Chiesi Global Rare Diseases and Protalixs submission to update the dosing regimen of pegunigalsidase alfa.

59

59

PharmExec

DECEMBER 10, 2024

When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Leads 52

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmaceutical Technology

DECEMBER 10, 2024

An improved price discount and new evidence from Santhera has changed NICEs tune following a recommendation shun earlier this year.

59

59

PharmExec

DECEMBER 10, 2024

When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.

Pharma 52

Pharma Manufacturing Pharmaceutical Leads 52

Pharmaceutical Technology

DECEMBER 10, 2024

The US FDA has accepted a submission from GSK to review a new indication of Nucala (mepolizumab) as an add-on maintenance treatment for COPD.

FDA 59

FDA 59

Pharmaceutical Commerce

DECEMBER 10, 2024

A panel uncovers how distribution channels are aligning commercialization efforts.

Distribution 52

Distribution 52

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTech

DECEMBER 10, 2024

Shilpa Gadgil, PhD (VP, Head of Process and Analytical Development, Head of CDMO Development) discusses Enzene's new technologies and the New Jersey site capabilities.

52

52

Pharmaceutical Commerce

DECEMBER 10, 2024

Conference keynote speech examines the industrys critical developments of 2024 and offers a strategic outlook for next year.

52

52

Contrarian Sales Techniques

DECEMBER 10, 2024

When you think of medical sales in a multinational pharmaceutical company (MNC), you might picture a fast-paced, target-driven job. But heres the thing: Its not just about hitting quotas or visiting doctors. If you play your cards right, medical sales can be the start of a career that takes you to regional or even global leadership roles. So, how does career progression look in medical sales for an MNC in Malaysia?

Medical sales 52

Medical sales Sales Medical Key account management 52

Pharmaceutical Commerce

DECEMBER 10, 2024

Our December analysis of the twists and turns in the Drug Supply Chain Security Act is a timely one, as the FDA recently again pushed back the deadline for complying with new mandates on tracking and tracing drugs at the package level.

FDA 52

FDA 52

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

PM360

DECEMBER 10, 2024

NEW YORK , Dec. 9, 2024 /PRNewswire/ — Omnicom (NYSE: OMC ) and The Interpublic Group of Companies, Inc. (NYSE: IPG ) (“Interpublic”) today announced their Boards of Directors have unanimously approved a definitive agreement pursuant to which Omnicom will acquire Interpublic in a stock-for-stock transaction. The combined company will bring together the industry’s deepest bench of marketing talent, and the broadest and most innovative services and products, driven by the m

Marketing 52

Marketing Sales CRM Government 52

Pharmaceutical Commerce

DECEMBER 10, 2024

Click the title above for a link to open the Pharmaceutical Commerce December 2024 issue in an interactive PDF format.

Pharmaceutical 52

Pharmaceutical 52

Copyright Clearance Center

DECEMBER 10, 2024

London, 10 December 2024: The Pistoia Alliance , a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center), a leader in advancing copyright, accelerating knowledge, and powering innovation, on the impact of AI and copyright legislation on pharma R&D.

Patients 52

Patients Prescription FDA Safety 52

Pharmaceutical Commerce

DECEMBER 10, 2024

Access Insights Conference delves into the latest obstacles, while mapping out potential solutions to address them.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharma Marketing Network

DECEMBER 10, 2024

In the ever-evolving healthcare marketing landscape, video advertising has emerged as a highly effective and influential medium for both publishers and advertisers. From capturing attention to driving conversions, video has become an essential tool in healthcare advertising. But what makes video so impactful for both publishers and advertisers in this industry?

Healthcare 52

Healthcare Healthcare Marketing Medical 52

Pharmaceutical Commerce

DECEMBER 10, 2024

The value of this sometimes-unheralded technology to the pharma industryas well as potential use casesare starting to come to light.

Pharma 52

Pharma 52

PharmExec

DECEMBER 10, 2024

For pharma manufacturers, the primary requirement for working with high-profile clients is matching their organizational level of urgency and organization.

Manufacturing 52

Manufacturing Pharma 52

PharmaTech

DECEMBER 10, 2024

Novartis will in-license PTC's PTC518 program, which has the potential become the first oral disease-modifying therapy for Huntington's disease.

52

52

Advertiser: ZoomInfo

Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The reason is clear: intent can provide you with massive amounts of data that reveal sales opportunities earlier than ever before.

Sales